There is evidence that NRP-1, despite the lack of catalytic activity, also serves as an independent mediator of blood vessel development in cancerous tumors and that its expression on the surface of cancerous cells is increased and often associated with poor prognosis [10,11,12,13]. This evidence concerns the gene NRP1 and cancer.